Today's Hours: 8:00am - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    volume editors, Barbara A. Centeno, Jasreman Dhillon.
    Summary: "This book provides a comprehensive review of entities that may be encountered in pancreatic cytology. It is designed for cytotechnologists, pathology trainees, pathologists, and cytopathologists. It is also a useful guide for advanced endoscopists performing EUS-guided FNA, and surgeons and oncologists treating patients with pancreatic disease wanting to understand their pathology reports"-- Provided by publisher.

    Contents:
    Introduction to pancreatic pathology and fine-needle aspiration cytology / Dhillon, J.
    Processing of fine-needle aspiration specimens from pancreatic lesions / Dhillon, J.
    Imaging of pancreatic tumors / Morse, B., Klapman, J.
    Normal components and contaminants / Dhillon, J.
    Non-neoplastic masses of the pancreas / Centeno, B.A., Thomas, S.
    Non-neoplastic and neoplastic cysts of the pancreas / Centeno, B.A., Thomas, S.
    Pancreatic ductal adenocarcinoma / Betancourt, M., Dhillon, J.
    Non-ductal tumors of the pancreas / Dhillon, J.
    Metastases, secondary tumors, and lymphomas of the pancreas / Centeno, B.A.
    Mesenchymal tumors of the pancreas / Dhillon, J.
    Digital Access Karger 2020
  • Article
    Lasky FD, Al Razi J, Karmen A.
    Clin Chem. 1978 Aug;24(8):1381-5.
    In the usual sequential addition enzyme immunoassays for drugs, the activity of the drug-labeled enzyme decreases continuously with time as more of it is bound to antibody. Sensitivity also decreases; the activity immediately after mixing is the most sensitive indicator of drug concentration. The reaction of enzyme-drug with antibody can be stopped by saturating the antibody with a larger quantity of unlabeled drug, which reacts with the antibody faster than does the enzyme-labeled drug. When drug is added soon after the reaction starts, the enzyme activity is stabilized and the sensitivity to small quantities of antigen is increased. This approach, with modification, should be applicable to sequential immunoassays in which other kinds of labels are used. The enzyme activity can be measured for a longer time, with the predictable increase in precision, as well as the ability to detect smaller quantities, to use less reagent, and to use end-point rather than kinetic assays.
    Digital Access Access Options